Long-term inhaled dry powder mannitol improves lung function in CF
Friday, December 16, 2011 - 04:32
in Health & Medicine
Adding inhaled dry powder mannitol to standard therapy for cystic fibrosis produced sustained improvement in lung function for up to 52 weeks, according to a new study. Along with the treatment's efficacy and good safety profile, the convenience and ease of administration of mannitol treatment may improve adherence with therapy in these patients.
